GuidelineTransfusion2015
It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
Guideline in Transfusion, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 1 synthesis or guideline pooled it, 194 citations in OpenAlex.
- Misclassification of RhD variants among pregnant women: a systematic review.Journal of medicine and life · 2023Pooled it
- Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.Transfusion · 2018Trial
- Refining RhIG Prophylaxis Guidelines: Asian-Type DEL as RhD-Positive and Unresolved Dosing Challenges in RhD Epitope-Deficient Variants.Annals of laboratory medicine · 2026Article
- Prevalence of Serologic Weak D Phenotype in Iranian Blood Donors: A Nationwide Retrospective Cross-Sectional Study.Health science reports · 2026Article
- On the Differentiation of Auto- and Allo-Anti-D: The Significance of DAT and Autocontrol.Iranian journal of pathology · 2026Article
- RhD variants: Detected despite 3+ testing in gel.Transfusion · 2026Article
- Genetic diversity of the RHD gene in blood donors from the Brazilian Central-West.Hematology, transfusion and cell therapy · 2026Article
- A serologic weak D expressed by a combined weak D type 1/41.0.1 allele.Transfusion · 2026Article
- Rhesus Box as the Primary Mechanism of RHD Gene Deletion in RhD-Negative Blood Donors from Eastern Iran.International journal of hematology-oncology and stem cell research · 2026Article
- The Complexity of Weak Rhesus Positivity in Pregnancy: Challenges and Management-A Case Report.Clinical practice and cases in emergency medicine · 2025Article
- Red blood cell alloimmunization and pregnancy: Diagnosis and management.Pregnancy (Hoboken, N.J.) · 2025Review
- Weak D phenotype in transfusion medicine and obstetrics: Challenges and opportunities.World journal of experimental medicine · 2025Review
- IntegratingMedicina (Kaunas, Lithuania) · 2025Article
- Assessment of Unexpected (Non-ABO) Red Blood Cell Antibodies and Their Associated Clinical Conditions Among Patients and Blood Donors Attending University Teaching Hospital of Kigali (CHUK) and Rwanda Blood Transfusion Division.Advances in hematology · 2025Article
- Genomic characterization of clinically significant blood group variants in Aboriginal Australians.Blood transfusion = Trasfusione del sangue · 2024Article
- Maternal red blood cell alloimmunization prevalence in the United States.Blood advances · 2024Article
- A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite NormalTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024Article
- Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).Annals of laboratory medicine · 2024Review
- Resolution ofInternational journal of molecular sciences · 2024Article
- Variant RHD alleles and Rh immunization in patients with sickle cell disease.British journal of haematology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 6 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.